Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional

Radiation Therapy With or Without Chemotherapy in Treating Patients With Advanced Cancer of the Larynx

ClinicalTrials.gov ID: NCT00002496

Public ClinicalTrials.gov record NCT00002496. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 18, 2026, 9:46 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

PHASE III TRIAL TO PRESERVE THE LARYNX: INDUCTION CHEMOTHERAPY AND RADIATION THERAPY VERSUS CONCOMITANT CHEMOTHERAPY AND RADIATION THERAPY VERSUS RADIATION THERAPY

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Radiation therapy uses high-energy x-rays to damage tumor cells. It is not yet known if chemotherapy plus radiation therapy is more effective than radiation therapy alone in treating patients with advanced cancer of the larynx. PURPOSE: Randomized phase III trial to compare the effectiveness of radiation therapy with or without chemotherapy in treating patients with advanced cancer of the larynx.

Study identification

NCT ID
NCT00002496
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Enrollment
Not listed

Conditions and interventions

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Aug 1992 (Type not available)
Primary completion
Aug 2002 (Actual)
Completion
Nov 2013 (Actual)
Last update posted
Jan 24, 2014

1992 – 2013

United States locations

U.S. sites
17
U.S. states
12
U.S. cities
15
Facility City State ZIP Site status
CCOP - Colorado Cancer Research Program, Inc. Denver Colorado 80209-5031 —
H. Lee Moffitt Cancer Center and Research Institute Tampa Florida 33612 —
Veterans Affairs Medical Center - Atlanta (Decatur) Decatur Georgia 30033 —
CCOP - Illinois Oncology Research Association Peoria Illinois 61602 —
CCOP - Carle Cancer Center Urbana Illinois 61801 —
Indiana University Cancer Center Indianapolis Indiana 46202-5265 —
Veterans Affairs Medical Center - Indianapolis (Roudebush) Indianapolis Indiana 46202 —
CCOP - Iowa Oncology Research Association Des Moines Iowa 50309-1016 —
New England Medical Center Hospital Boston Massachusetts 02111 —
Beth Israel Deaconess Medical Center Boston Massachusetts 02215 —
CCOP - Kalamazoo Kalamazoo Michigan 49007-3731 —
CCOP - Metro-Minnesota Saint Louis Park Minnesota 55416 —
Veterans Affairs Medical Center - East Orange East Orange New Jersey 07018-1095 —
CCOP - Northern New Jersey Hackensack New Jersey 07601 —
Ireland Cancer Center Cleveland Ohio 44106-5065 —
Hahnemann University Hospital Philadelphia Pennsylvania 19102-1192 —
University of Pittsburgh Cancer Institute Pittsburgh Pennsylvania 15213 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 1 non-U.S. site.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00002496, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jan 24, 2014 · Synced Oct 18, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT00002496 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →